Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-5703

CRP: Replace term FIT DNA with term Stool DNA with FIT

XMLWordPrintable

    • Icon: Other Other
    • Resolution: Resolved
    • Icon: Moderate Moderate
    • None
    • ​​We plan to move forward with the proposed change during this Annual Update​
    • Hide
      Brief description of measure
      CMS130: Colorectal Cancer Screening:
      Percentage of adults 45-75 years of age who had appropriate screening for colorectal cancer.

      Description of issue
      ​​The measure steward would like to update the terminology "FIT DNA" used in the measure to better align with the current industry term.

      Goal of review
      Obtain clinical feedback
      Show
      Brief description of measure CMS130: Colorectal Cancer Screening: Percentage of adults 45-75 years of age who had appropriate screening for colorectal cancer. Description of issue ​​The measure steward would like to update the terminology "FIT DNA" used in the measure to better align with the current industry term. Goal of review Obtain clinical feedback
    • Hide
      Proposed solution
      ​Clinical recommendation statement before:
      Appropriate screenings are defined by any one of the following:
      -Fecal occult blood test (annually)
      -FIT-DNA test (every 3 years)
      [...]

      Clinical recommendation statement after:
      Appropriate screenings are defined by any one of the following:
      -Fecal occult blood test (annually)
      -Stool DNA (sDNA) with FIT test (every 3 years)
      [...]


      Numerator header language before:
      Patients with one or more screenings for colorectal cancer. Appropriate screenings are defined by any one of the following criteria: 
      - Fecal occult blood test (FOBT) during the measurement period
      - FIT-DNA during the measurement period or the two years prior to the measurement period
      [...]

      Numerator header language after:
      Patients with one or more screenings for colorectal cancer. Appropriate screenings are defined by any one of the following criteria: 
      - Fecal occult blood test (FOBT) during the measurement period
      - Stool DNA (sDNA) with FIT test during the measurement period or the two years prior to the measurement period
      [...]


      Definition before:
      define "Fecal Immunochemical Test DNA Performed"
      ["Laboratory Test, Performed": "FIT DNA"] FitDNA
        where FitDNA.result is not null
          and Global."LatestOf" ( FitDNA.relevantDatetime, FitDNA.relevantPeriod ) during [...]

      Definition after:
      define "Fecal Immunochemical Test DNA Performed"
      ["Laboratory Test, Performed": "sDNA FIT Test"] sDNATest
        where sDNATest.result is not null
          and Global."LatestOf" ( sDNATest.relevantDatetime, sDNATest.relevantPeriod ) during [...]


      Terminology before:
      valueset "FIT DNA" (2.16.840.1.113883.3.464.1003.108.12.1039)

      Terminology after;
      valueset "sDNA FIT Test" (2.16.840.1.113883.3.464.1003.108.12.1039)

      Rationale for change
      Updating the term "FIT DNA" with "Stool DNA (sDNA) with FIT Test" throughout the measure header and logic will align with the current industry term. Additionally, this change will provide clarity that Fecal Immunochemical Test (FIT) and DNA test are both required.
      Show
      Proposed solution ​Clinical recommendation statement before: Appropriate screenings are defined by any one of the following: -Fecal occult blood test (annually) -FIT-DNA test (every 3 years) [...] Clinical recommendation statement after: Appropriate screenings are defined by any one of the following: -Fecal occult blood test (annually) -Stool DNA (sDNA) with FIT test (every 3 years) [...] Numerator header language before: Patients with one or more screenings for colorectal cancer. Appropriate screenings are defined by any one of the following criteria:  - Fecal occult blood test (FOBT) during the measurement period - FIT-DNA during the measurement period or the two years prior to the measurement period [...] Numerator header language after: Patients with one or more screenings for colorectal cancer. Appropriate screenings are defined by any one of the following criteria:  - Fecal occult blood test (FOBT) during the measurement period - Stool DNA (sDNA) with FIT test during the measurement period or the two years prior to the measurement period [...] Definition before: define "Fecal Immunochemical Test DNA Performed" ["Laboratory Test, Performed": "FIT DNA"] FitDNA   where FitDNA.result is not null     and Global."LatestOf" ( FitDNA.relevantDatetime, FitDNA.relevantPeriod ) during [...] Definition after: define "Fecal Immunochemical Test DNA Performed" ["Laboratory Test, Performed": "sDNA FIT Test"] sDNATest   where sDNATest.result is not null     and Global."LatestOf" ( sDNATest.relevantDatetime, sDNATest.relevantPeriod ) during [...] Terminology before: valueset "FIT DNA" (2.16.840.1.113883.3.464.1003.108.12.1039) Terminology after; valueset "sDNA FIT Test" (2.16.840.1.113883.3.464.1003.108.12.1039) Rationale for change Updating the term "FIT DNA" with "Stool DNA (sDNA) with FIT Test" throughout the measure header and logic will align with the current industry term. Additionally, this change will provide clarity that Fecal Immunochemical Test (FIT) and DNA test are both required.

          edave Mathematica EC eCQM Team
          edave Mathematica EC eCQM Team
          Votes:
          0 Vote for this issue
          Watchers:
          4 Start watching this issue

            Created:
            Updated:
            Resolved: